Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
    • IPOs
  • inderesTV
  • Portfolio
  • Forum
  • Discovery
  • Q&A
  • About Us
    • Our Coverage
    • Team

CellaVision

156.40 SEK

+2.89 %

1,475 following

CEVI

NASDAQ Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Income statement

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for CellaVision

2019202020212022202320242025
Revenue461.8471.4565.6639.3677.3723.2759.0
growth-%2.1 %20.0 %13.0 %5.9 %6.8 %4.9 %
EBITDA146.7142.9196.2198.0207.0219.0241.4
EBIT126.6110.3162.7158.3167.1177.7202.1
Profit before taxes129.2112.2158.3148.4164.2176.9194.3
Net income99.289.5125.3118.3130.3140.7153.1
EPS4.163.755.254.965.465.906.42
Dividend0.000.752.002.002.252.502.75
Dividend ratio0.0 %20.0 %38.1 %40.3 %41.2 %42.4 %42.8 %

Profitability and return on capital

2019202020212022202320242025
EBITDA-%31.8 %30.3 %34.7 %31.0 %30.6 %30.3 %31.8 %
EBIT-%27.4 %23.4 %28.8 %24.8 %24.7 %24.6 %26.6 %
ROE28.5 %20.8 %23.1 %18.4 %18.2 %17.3 %17.2 %
ROI15.5 %13.4 %15.2 %13.3 %14.0 %13.9 %14.0 %
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.